Novel ester derivatives of betulin with AZT, d4T, and 3TC were synthesized and assessed for antitumor activities against the KB and HepG2 human cancer cell lines in vitro by MTT assay. Some derivatives displayed high anticancer properties, with IC50 values between 1 and 21 μM on the two cancer cell lines.
FlekhterO.B., MedvedevaN.I., KarachurinaL.T., BaltinaL.A., ZarudiiF.S., GalinF.Z., TolstikovG.A. (2002) Synthesis and anti-inflammatory activity of new acylated betulin derivatives. Pharmaceutical Chemistry Journal, 36, 488–491.
3.
ChueK.T., ChangM.S., TenL.N. (2011) Synthesis and antibacterial activity of betulin esters. Chemistry of Natural Compounds, 47, 583–586.
4.
(a) MullauerF.B., KesslerJ.H., MedemaJ.P. (2009) Betulin is a potent anti-tumor agent that is enhanced by cholesterol. Plos One, 4, e5361; (b) Thibeault D, Gauthier C, Legault J, Bouchard J, Dufour P, Pichette A. (2007) Synthesis and structure–activity relationship study of cytotoxic germanicane- and lupane-type 3β-O-monodesmosidic saponins starting from betulin. Bioorganic & Medicinal Chemistry, 15, 6144–6157.
5.
(a) ChintharlapalliS., PapineniS., RamaiahS.K., SafeS. (2007) Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Research, 67, 2816–2823; (b) Gauthier C, Legault J, Lavoie S, Rondeau S, Tremblay S, Pichette A. (2009) Synthesis and cytotoxicity of bidesmosidic betulin and betulinic acid saponins. Journal of Natural Products, 72, 72–81; (c) Csuk R, Barthel A, Sczepek R, Slewert B, Schwarz S. (2011) Synthesis, encapsulation and antitumor activity of new betulin derivatives. Arch Pharm Chemistry in Life Science, 1, 37–49.
6.
(a) YangS.J., LiuM.C., XiangH.M., ZhaoQ., XueW., YangS. (2015) Synthesis and in vitro antitumor evaluation of betulin acid ester derivatives as novel apoptosis inducers. European Journal of Medicinal Chemistry, 102, 249–255; (b) Chen LC, Wang HK, Kahiwada Y, Shen JK, Cosentino LM, Chen CH, Yang LM, Lee KH. (1998) Anti-AIDS agents. 34.† Synthesis and structure-activity relationships of betulin derivatives as anti-hiv agents. Journal of Medicinal Chemistry, 41, 4648–4657; (c) Kashiwada Y, Lee KH. (2001) 3,28-Di-O-(dimethylsuccinyl)-betulin isomers as anti-HIV agents. Bioorganic & Medicinal Chemistry Letters, 11, 183–185; (d) Xiong J, Kashiwada Y, Chen CH, Qiuan K, Morris-Natschke SL, Lee KH, Takaishi Y. (2010) Conjugates of betulin derivatives with AZT as potent anti-HIV agents. Bioorganic & Medicinal Chemistry, 18, 6451–6469; (e) Our submitted data; (f) Bori ID, Hung HY, Qian K, Chen CH, Morris-Natschke SL, Lee KH. (2012) Anti-AIDS agents 88. Anti-HIV conjugates of betulin and betulinic acid with AZT prepared via click chemistry. Tetrahedron Letters, 53, 1987–1989; (g) Kommera H, Kaluderovic GN, Kalbitz J, Paschke R. (2011) Lupane triterpenoids - betulin and betulinic acid derivatives induce apoptosis in tumor cells. Investigational New Drugs, 29, 266–272.
7.
(a) LaurenceJ. (1996) Preclinical data on the antiretroviral activity of AZT. AIDS Patient Care STDS, 10, 208–209; (b) Moodley J, Moodley D, Pillay K, Coovadia H, Saba J, van Leeuwen R, Goodwin C, Harrigan PR, Moore KH, Stone C, Plumb R, Johnson MA. (1998) Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring. Journal of Infectious Diseases, 178, 1327–1333; (c) Riddler SA, Anderson RE, Mellors JW. (1995) Antiretroviral activity of stavudine (2′,3′-didehydro-3′-deoxythymidine, D4T). Antiviral Research, 27, 189–203.
8.
(a) MattsonD.M., AhmadI.M., DayalD., ParsonsA.D., Aykin-BurnsN., LiL., OrcuttK.P., SpitzD.R., DornfeldK.J., SimonsA.L. (2009) Cisplatin combined with zidovudine enhances cytotoxicity and oxidative stress in human head and neck cancer cells via a thiol-dependent mechanism. Free Radical Biology and Medicine, 46, 232–237; (b) Wagner CR, Ballato G, Akanni AO, McIntee EJ, Larson RS, Chang S, Abul-Hajj YJ. (1997) Potent growth inhibitory activity of zidovudine on cultured human breast cancer cells and rat mammary tumors. Cancer Research, 57, 2341–2345; (c) Momiyama K, Nagai H, Ogino Y, Mukouzu T, Matsui D, Kogame M, Matsui T, Wakui N, Shinohara M, Igarashi Y, Sumino Y. (2015) The importance of lamivudine therapy in liver cirrhosis patients related HBV with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy. Clinical Cancer Drugs, 2, 112–118; (d) Wu YW, Xiao Q, Jiang YY, Fu H, Ju Y, Zhao YF. (2004) Synthesis, in vitro anticancer evaluation, and interference with cell cycle progression of N-phosphoamino acid esters of zidovudine and stavudine. Nucleosides, nucleotides & nucleic acids, 23, 1797–1811.
9.
(a) AnhD.T.T., ChinhP.T., AnhL.T., HieuT.H., HaV.T.T., SoldatenkovA.T., TuyenN.V. (2015) New hybrids between triterpenoid acids and nucleoside HIV-RTinhibitors. Mendeleev Communications, 25, 96–98; (b) Anh DTT, Tuyet NTK, Chinh PT, Thanh NH, Cham BT, Tien DD, D'hooghe M, Tuyen NV. (2014) Synthesis and cytotoxic evaluation of novel ester-triazole-linked triterpenoid–AZT conjugates. Bioorganic & Medicinal Chemistry Letters, 24, 5190–5194; (c) Anh DTT; Tuyet NTK, Chinh PT, Thanh NH, Cham BT, Phuong HT, Boi LV, Tuyen NV, D'hooghe M. (2015) Synthesis and cytotoxic evaluation of novel amide–triazole-linked triterpenoid–AZT conjugates, Tetrahedron Letters, 56, 218–224.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
